05:08 PM EDT, 08/12/2025 (MT Newswires) -- Adam Morgan, Director, on August 08, 2025, executed a purchase for 1,766,546 shares in Heron Therapeutics ( HRTX ) for $2,649,819. Following the Form 4 filing with the SEC, Morgan has control over a total of 8,823,067 common shares of the company, with 69,777 shares held directly and 8,753,290 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818033/000092189525002160/xslF345X05/form412927018_08122025.xml